FDAnews
www.fdanews.com/articles/130731-hypertension-study-shows-benicar-superior-to-cozaar

Hypertension Study Shows Benicar Superior to Cozaar

October 1, 2010
New study results show that patients treated with Benicar (olmesartan medoxomil) 40 mg once daily had significantly greater reductions in blood pressure and higher rates of goal attainment than patients receiving Cozaar (losartan potassium) 100 mg once daily at week 8, according to findings of a new head-to-head study.
Earth Times